Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Increase in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totaling 734 shares, a growth of 79.9% from the April 30th total of 408 shares. Currently, 0.2% of the company’s stock are short sold. Based on an average daily volume of 2,604 shares, the days-to-cover ratio is currently 0.3 days.

Institutional Trading of Innovator IBD Breakout Opportunities ETF

A number of large investors have recently made changes to their positions in BOUT. Comprehensive Wealth Management LLC increased its stake in shares of Innovator IBD Breakout Opportunities ETF by 122.0% during the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after buying an additional 12,859 shares during the period. Susquehanna International Group LLP increased its stake in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after buying an additional 7,817 shares during the period. Finally, Osaic Holdings Inc. increased its stake in shares of Innovator IBD Breakout Opportunities ETF by 39.7% during the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after buying an additional 597 shares during the period.

Innovator IBD Breakout Opportunities ETF Stock Performance

Shares of BOUT opened at $47.70 on Thursday. The stock has a market capitalization of $16.70 million, a PE ratio of 28.69 and a beta of 1.05. Innovator IBD Breakout Opportunities ETF has a 1 year low of $35.05 and a 1 year high of $48.05. The company’s 50-day simple moving average is $43.91 and its 200-day simple moving average is $40.28.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.